High-Throughput Drug Screening of Clear Cell Ovarian Cancer Organoids Reveals Vulnerability to Proteasome Inhibitors and Dinaciclib and Identifies AGR2 as a Therapeutic Target.
Yoshimura T, Kamatani T, Ookubo A, Takahashi M, Itoh M, Ebisudani T, Masugi Y, Toyonaga T, Hamamoto J, Saotome K, Sakai K, Yoshihama T, Moritoki N, Shibata S, Yasuda H, Sato T, Sato TA, Aoki D, Yamagami W, Tsunoda T, Chiyoda T.
Yoshimura T, et al. Among authors: sakai k.
Cancer Res Commun. 2025 Jun 1;5(6):1018-1033. doi: 10.1158/2767-9764.CRC-25-0024.
Cancer Res Commun. 2025.
PMID: 40459063
Free PMC article.